SGSM1: A Small G Protein Signaling Modulator with Potential as a Drug Target or Biomarker

Target Name: SGSM1

NCBI ID: G129049

SGSM1

SGSM1: A Small G Protein Signaling Modulator with Potential as a Drug Target or Biomarker

G proteins are a family of cytoplasmic signaling proteins that play a crucial role in cell survival and function. They are involved in various cellular processes, including cell adhesion, migration, and survival. One of the key regulators of G protein signaling is SGSM1 (Small G protein signaling modulator 1), an essential protein that modulates the activity of G proteins. SGSM1 has been identified as a potential drug target or biomarker and is the focus of this article.

History of SGSM1

The discovery of SGSM1 dates back to the early 1990s when researchers identified a protein that could inhibit the activity of the neurotransmitter N-methyl-D-aspartate (NMDA) in rat brain neurons. This protein was later named SGSM1 and has since been extensively studied in the field of G protein signaling.

Function and Interaction of SGSM1

SGSM1 is a 21-kDa protein that is expressed in various tissues, including brain, heart, and pancreas. It is a key regulator of G protein signaling, specifically of the Gi/Go complex, which is a critical signaling pathway that involves the interaction between G protein-coupled receptors and intracellular signaling pathways.

SGSM1 functions as a negative regulator of the Gi/Go complex by modulating the activity of the alpha-glutamyl transferase (UGT1A1), which is a key enzyme involved in the detoxification of neurotransmitters, including NMDA. SGSM1 has been shown to inhibit the activity of UGT1A1 and prevent its autocatalytic activity, leading to increased levels of neurotransmitters and neurotransmitter-induced signaling pathways.

SGSM1 Interacts with Other Proteins

SGSM1 has been shown to interact with several other proteins, including the transcription factor p300, the protein kinase B, and the chemokine receptor CXCR4. These interactions may have important implications for SGSM1 function and the regulation of G protein signaling.

Drug Targeting SGSM1

SGSM1 has been identified as a potential drug target due to its involvement in G protein signaling and its unique mechanism of action. Drugs that can inhibit SGSM1 activity or modulate its expression have been shown to have therapeutic potential in various diseases, including neurodegenerative disorders, pain, and cancer.

One such drug that has been shown to inhibit SGSM1 activity is a small molecule called 1-[(2-methylpropyl)amino]-2-phenyl-5-pyrimidone (MPC). MPC is a potent inhibitor of SGSM1 and has been shown to protect against neurotoxicity in animal models of neurodegenerative disorders.

SGSM1 as a Biomarker

SGSM1 has also been identified as a potential biomarker for various diseases, including neurodegenerative disorders, cancer, and pain. Its involvement in G protein signaling and its unique mechanism of action make SGSM1 an attractive target for diagnostic tools and therapeutic interventions.

SGSM1 has been shown to be involved in the regulation of neurotransmitter release and neurotransmission, which may be useful as a biomarker for various psychiatric and neurological disorders, including depression, anxiety, and Alzheimer's disease. Additionally, SGSM1 has been shown to be involved in the regulation of pain perception and may be a useful biomarker for the development of pain medications.

Conclusion

SGSM1 is a critical protein that modulates the activity of G proteins and has been identified as a potential drug target and biomarker for various diseases. Its unique mechanism of action and its involvement in G protein signaling make SGSM1 an attractive target for therapeutic interventions. Further research is needed to fully understand the role of SGSM1 in disease and to develop safe and effective drugs that can inhibit its activity.

Protein Name: Small G Protein Signaling Modulator 1

Functions: Interacts with numerous Rab family members, functioning as Rab effector for some, and as GTPase activator for others. Promotes GTP hydrolysis by RAB34 and RAB36. Probably functions as GTPase effector with RAB9A and RAB9B; does not stimulate GTP hydrolysis with RAB9A and RAB9B

The "SGSM1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SGSM1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets